Skip to main content
. 2010 Sep 25;398(7):2943–2948. doi: 10.1007/s00216-010-4192-8

Table 2.

Measured pemetrexed concentrations in plasma from NSCLC patients (n = 3)

Patient code Pemetrexed concentration (pmol/μL)a mean (SD) Genderb Age
A 80.0 (9.3) f 51
A 142.7 (20.3)c f 51
B 8.7 (1.4) f 56
C 63.0 (7.0) m 66
C 60.7 (8.3)c m 66
D 33.3 (4.9) m 75
E 42.7 (9.7) m 48
F 49.1 (10.8) f 56
G 121.0 (20.2) m 61

aResults summarize 10 spots per patient sample

bFemale (f) and male (m)

cSecond administration of 500 mg/m2, 3 weeks after first administration